Annual EBITDA
-$69.48 M
-$35.79 M-106.24%
December 31, 2021
Summary
- As of February 10, 2025, GMTX annual EBITDA is -$69.48 million, with the most recent change of -$35.79 million (-106.24%) on December 31, 2021.
- During the last 3 years, GMTX annual EBITDA has fallen by -$35.79 million (-106.24%).
Performance
GMTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$3.24 M
+$3.81 M+54.05%
September 30, 2022
Summary
- As of February 10, 2025, GMTX quarterly EBITDA is -$3.24 million, with the most recent change of +$3.81 million (+54.05%) on September 30, 2022.
- Over the past year, GMTX quarterly EBITDA has increased by +$15.15 million (+82.40%).
Performance
GMTX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$43.13 M
+$15.15 M+26.00%
September 30, 2022
Summary
- As of February 10, 2025, GMTX TTM EBITDA is -$43.13 million, with the most recent change of +$15.15 million (+26.00%) on September 30, 2022.
- Over the past year, GMTX TTM EBITDA has increased by +$1.43 million (+3.20%).
Performance
GMTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
GMTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -106.2% | +82.4% | +3.2% |
| 3 y3 years | -106.2% | +66.0% | -353.3% |
| 5 y5 years | -106.2% | +66.0% | -353.3% |
GMTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | +446.7% | at high | +61.1% |
| 5 y | 5-year | +106.2% | at low | -144.8% | +468.3% | +353.3% | +61.1% |
| alltime | all time | +106.2% | at low | -144.8% | +468.3% | +353.3% | +61.1% |
Gemini Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$3.24 M(-54.0%) | -$43.13 M(-26.0%) |
| Jun 2022 | - | -$7.04 M(-53.6%) | -$58.29 M(-13.7%) |
| Mar 2022 | - | -$15.16 M(-14.3%) | -$67.51 M(-2.8%) |
| Dec 2021 | -$69.48 M | -$17.69 M(-3.8%) | -$69.48 M(+55.9%) |
| Sep 2021 | - | -$18.39 M(+13.1%) | -$44.56 M(+30.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$16.26 M(-5.1%) | -$34.05 M(+39.7%) |
| Mar 2021 | - | -$17.14 M(-337.1%) | -$24.37 M(+45.5%) |
| Dec 2020 | -$33.69 M | $7.23 M(-191.7%) | -$16.75 M(-30.1%) |
| Sep 2020 | - | -$7.88 M(+19.6%) | -$23.98 M(+48.9%) |
| Jun 2020 | - | -$6.59 M(-30.8%) | -$16.10 M(+69.2%) |
| Mar 2020 | - | -$9.52 M | -$9.52 M |
FAQ
- What is Gemini Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Gemini Therapeutics?
- What is Gemini Therapeutics annual EBITDA year-on-year change?
- What is Gemini Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Gemini Therapeutics?
- What is Gemini Therapeutics quarterly EBITDA year-on-year change?
- What is Gemini Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Gemini Therapeutics?
- What is Gemini Therapeutics TTM EBITDA year-on-year change?
What is Gemini Therapeutics annual EBITDA?
The current annual EBITDA of GMTX is -$69.48 M
What is the all time high annual EBITDA for Gemini Therapeutics?
Gemini Therapeutics all-time high annual EBITDA is -$33.69 M
What is Gemini Therapeutics annual EBITDA year-on-year change?
Over the past year, GMTX annual EBITDA has changed by -$35.79 M (-106.24%)
What is Gemini Therapeutics quarterly EBITDA?
The current quarterly EBITDA of GMTX is -$3.24 M
What is the all time high quarterly EBITDA for Gemini Therapeutics?
Gemini Therapeutics all-time high quarterly EBITDA is $7.23 M
What is Gemini Therapeutics quarterly EBITDA year-on-year change?
Over the past year, GMTX quarterly EBITDA has changed by +$15.15 M (+82.40%)
What is Gemini Therapeutics TTM EBITDA?
The current TTM EBITDA of GMTX is -$43.13 M
What is the all time high TTM EBITDA for Gemini Therapeutics?
Gemini Therapeutics all-time high TTM EBITDA is -$9.52 M
What is Gemini Therapeutics TTM EBITDA year-on-year change?
Over the past year, GMTX TTM EBITDA has changed by +$1.43 M (+3.20%)